SCHEMBL6178235

SCHEMBL6178235

C[C](OC1CCCCC1)OC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA12 O43570 2/20 0.48
CA9 Q16790 2/20 0.48
EPHX1 P07099 2/20 0.45
NAAA Q02083 2/20 0.41
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP19A1 P11511 3/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL191779 0.97 CA12 (0.46) CA1CA2CA12CA9EPHX1
SCHEMBL6179986 0.91 CA12 (0.40) CA1CA2CA12CA9EPHX1
SCHEMBL6175813 0.84 CA12 (0.32) CA1CA2CA12CA9EPHX1
SCHEMBL2701871 0.82 CA1 (0.48) CA1CA2CA12CA9EPHX1
SCHEMBL2702116 0.79
SCHEMBL23506964 0.78 EPHX1 (0.52) CA1CA2CA12CA9EPHX1
SCHEMBL200090 0.78 EPHX1 (0.52) CA1CA2CA12CA9EPHX1
SCHEMBL93396 0.78 EPHX1 (0.52) CA1CA2CA12CA9EPHX1
SCHEMBL28333231 0.78 CA12 (0.56) CA1CA2CA12CA9EPHX1
SCHEMBL22540554 0.78 EPHX1 (0.52) CA1CA2CA12CA9EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed